Shanghai Petrochemical Acrylic Polyester Products Obtained Authoritative Certification
China Resources Pharma's China Pharmaceutical Research Innovative Drug NIP003 Tablets Obtained Clinical Approval
Hengrui Medicine Gadobutrol Injection obtained drug registration certificate
Huahai Pharmaceutical's Nebivolol Tablets Obtained FDA Approval Number
Suzhou Yilian Bio's YL201 clinical trial application obtained the US FDA's implied license
Lihe Technology will invest 130 million yuan to obtain a 5% stake in Shanghai Survey and Design Research Institute
Mingde Bio's novel coronavirus antigen detection reagent obtains medical device registration certificate
pollen tubes in pistils" obtained an invention patent in South China Botanical Garden
The brand milk tea "Xingfutang" obtained the official halal certification in Indonesia
Tapentadol, a subsidiary of Renfu Pharmaceutical Holdings, obtained the tentative approval number of the US FDA
Jilin Aodong Shengmai Yin (Dangshenfang) obtained the approval notice for supplementary drug application
Renfu Medicine's Paracetamol and Oxycodone Sustained-Release Tablets Obtained the Approval Notice for Drug Clinical Trials
Jilin Aodong Holding Subsidiary Obtained 8 National Standard Chinese Medicine Formula Granules Listing Recording Certificates
Memantine Hydrochloride Sustained-Release Capsules, a subsidiary of Renfu Pharmaceutical Holdings Limited, obtained the drug registration certificate
Rundu Pharmaceutical Itopride Hydrochloride Tablets Obtained Drug Registration Approval
Yiling Pharmaceutical Lianhua Qingwen Capsules obtained the Liberia drug & health product registration certificate
Jiangsu Institute of Traditional Chinese Medicine obtained the implied license of Bakuchichi total glucoside capsules for clinical trials
Kelun Pharmaceutical Holdings subsidiary SKB378/HBM9378 injection obtained clinical trial notice
On February 21, Kelun Pharmaceutical issued an announcement saying that the SKB378/HBM9378 injection jointly developed
BGI's new crown antigen self-test product obtained EU CE access qualification
On February 7, BGI announced that the new crown antigen self-test product of its wholly-owned subsidiary BGI EuropeA/S
Enrico Ticagrelor Tablets Obtained Drug Registration Certificate